UBS/CALL/ABBOTT LABORATORIES/120/0.1/20.12.24 Share Price

Warrant

CH1227466989

Delayed Deutsche Boerse AG 06:12:24 27/06/2024 pm IST
0.133 EUR -19.88% Intraday chart for UBS/CALL/ABBOTT LABORATORIES/120/0.1/20.12.24
Current month+46.90%
1 month-11.23%
Date Price Change
27/24/27 0.133 -19.88%
26/24/26 0.166 -5.14%
25/24/25 0.175 -11.62%
24/24/24 0.198 -3.88%
21/24/21 0.206 -9.65%

Delayed Quote Deutsche Boerse AG

Last update June 27, 2024 at 06:12 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer UBS
WKN UL13N8
ISINCH1227466989
Date issued 21/02/2023
Strike 120 $
Maturity 20/12/2024 (176 Days)
Parity 10 : 1
Emission price 0.92
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.14
Lowest since issue 0.1
Spread 0.1
Spread %42.74%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104.9 USD
Average target price
125.2 USD
Spread / Average Target
+19.33%
Consensus